OSR Health, Inc. (OSRH): Total Liabilities

Annual figures by period end, from SEC filings.

$44.20M
As of 2025-12-31
$41.71M
As of 2026-06-30
+227.1%
3-year compound annual growth
2021-12-31: $707.2K2022-12-31: $1.26M2023-12-31: $4.11M2024-12-31: $32.03M2025-12-31: $44.20M$44.20M
2021-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$44.20M+38.0%2026-03-31, Balance as of period end
2024-12-31$32.03M+679.7%2026-03-31, Balance as of period end
2023-12-31$4.11M+225.2%2025-04-22, Balance as of period end
2022-12-31$1.26M+78.6%2024-04-17, Balance as of period end
2021-12-31$707.2Kn/a2023-03-31, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
OSR Health, Inc. (OSRH)2025-12-31$44.20M+38.0%
QHSLab, Inc. (USAQ)2025-12-31$546.1K-77.3%
Nuo Therapeutics, Inc. (AURX)2025-12-31$2.80M+314.7%
Femasys Inc (FEMY)2025-12-31$14.85M+46.5%
Tenon Medical, Inc. (TNON)2025-12-31$5.72M+47.7%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$6.65M+22.4%
Vycor Medical Inc (VYCO)2025-12-31$4.92M+4.9%
Lucid Diagnostics Inc. (LUCD)2025-12-31$29.51M+16.5%
Picard Medical, Inc. (PMI)2025-12-31$18.76M-47.7%

Compare OSRH, USAQ, AURX, FEMY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗